Novel methodologies for the trifluoromethylation of arenes and heteroarenes are highly demanded in the chemical and pharmaceutical industry. 1 In structure-activity relationship (SAR) studies, the introduction of fluorine atoms can greatly impact the electronic properties, acidity and lipophilicity of drug candidates. 2 These effects are due to the high electronegativity of the fluorine atom, to its relatively small radius and to the less polarizable nature of C-F bonds compared to C-H bonds. 1b The replacement of methyl groups with their trifluoromethyl counterparts represents a conservative substitution in terms of steric hindrance, while constituting a valuable strategy to block potential metabolically labile sites in drug candidates, prolonging their half-life and metabolic stability. 1a The initially reported trifluoromethylation protocols relied on transition-metal catalyzed cross-coupling methods, but suffered from the need for prefunctionalized substrates and for stoichiometric amounts of metal salts. 3 More recently, several strategies reported in the literature demonstrated the utility of photocatalytic protocols for the trifluoromethylation of alkenes, thiols, heterocycles and arenes. 4 The most commonly used trifluoromethyl sources include expensive Togni and Umemoto's reagents, unstable triflyl chloride (CF3SO2Cl), gaseous CF3I and readily available trifluoroacetic anhydride. 4e, 5 In addition, Langlois' reagent (CF3SO2Na) can be regarded as an easy-tohandle, inexpensive and solid trifluoromethylating agent, capable of generating CF3 radicals in the presence of a strong oxidant (e.g. tBuOOH). 6 7 As part of our interest to develop efficient continuous-flow protocols as enabling tools for drug discovery, we envisioned a photocatalytic strategy for the trifluoromethylation of a variety of highly functionalized heteroarenes, which are of interest in medicinal chemistry. 4a, 4b, 8 Such substrates are often ignored in many reports since these compounds are known to be highly challenging and thus low yielding. In order to develop a practical and widely applicable methodology, we opted to use the stable, inexpensive and solid Langlois reagent (CF3SO2Na) as trifluoromethyl source.
We commenced our investigations by performing luminescence quenching studies, which allowed us to rapidly select the optimal photocatalyst for our transformation (see Supporting Information). 9 Among the photocatalysts tested, the luminescence of both fac-Ir(ppy)3 and [Ir{dF(CF3)ppy}2](dtbpy)]PF6 was significantly quenched by increasing equivalents of CF3SO2Na, as depicted in Figure 1 . This suggests that the excited state of both photocatalysts can be oxidatively quenched by the Langlois reagent thus generating a CF3 radical. In particular, a high luminescence quenching percentage of 58% was obtained for [Ir{dF(CF3)ppy}2](dtbpy)]PF6 in the presence of 300 equivalents of Langlois' reagent, while 2500 equivalents of CF3SO2Na were needed to obtain a quenching percentage of only 44% in the case of fac-Ir(ppy)3 (Figure 1) (CF3SO2Na) were prepared in degassed acetonitrile and tested. Compared to the amount of catalyst present, the concentrations and number of equivalents of CF3SO2Na employed were the following: 25 mM, (=2500 equivalents), 50 mM, (=5000 equivalents); 100 mM, (=10000 equivalents). 300 mM (=30000 equivalents). For [Ir{dF(CF3)ppy}2](dtbpy)]PF6 a concentration of 0.3 mM (=300 equivalents and corresponding to reaction conditions) was also tested. For more details on the procedure followed and for the calculation of the quenching percentages see ESI.
The trifluoromethylation of caffeine was selected as the benchmark reaction for our optimization studies in flow ( Table  1) . The photoflow reactor consists of a Vapourtec UV-150 photoreactor equipped with a 10 mL capillary reactor (I.D. 1.3 mm), which was subjected to 450 nm irradiation (54 blue LEDs; 24W). DMSO was chosen as a suitable solvent, which ensured high solubility of the densely functionalized substrates and thus avoided the occurrence of microreactor clogging. At 40°C, unsatisfactory yields were observed in flow for the trifluoromethylated caffeine (Table 1 , Entries 1 and 2). We rationalized that the addition of an oxidant might assist the rearomatisation of the radical intermediate to the final product. Indeed, in the presence of 1 equivalent of (NH4)2S2O8 as an oxidant, an improved LC-MS yield of 48% was obtained ( . Control experiments revealed the photocatalytic nature of our protocol as little to no product was observed in the absence of either light or photocatalyst (Table 1 , Entries 8 and 9). Finally, irradiation of the reaction mixture with a 365 nm UV lamp resulted in 46% of the target compound, which can be attributed to the UV-tailing absorption of the iridium photocatalyst (Table 1, Entry 10 ). Nevertheless, it should be noted that, especially for the synthesis of densely functionalized drug candidates, irradiation with low-energy blue light is preferred over higher-energy ultraviolet in order to minimize the occurrence of side reactions and compound degradation. 11 With the optimized reaction conditions in hand, our photocatalytic trifluoromethylation strategy was evaluated on a wide range of heteroarenes and arenes as well as benzofused heterocycles (Scheme 1). We focused our attention specifically to halogen-bearing substrates, which are of high value for drug discovery programs. In these programs, such functionalized substrates are key building blocks for the very popular crosscoupling methods which allow to construct carbon-carbon or carbon-heteroatom bonds. 3-methyl and 2-methylindole derivatives 2b and 2c were obtained in satisfactory yields (62% and 69% respectively). Notably, the presence of an iodo substituent on the indole was well tolerated (2d; 50% isolated yield; C2:C3, 1:1). We then explored our transformation on a series of benzimidazole derivatives. Unlike indoles, benzimidazoles showed higher reactivity for the C4 and C6 position on the aromatic ring. 13 For example, trifluoromethyl benzimidazole 2e was obtained in 50% yield as a separable mixture of C4:C6 (3:2) isomers as well as the 2-Br trifluoromethyl derivative 2f (52% yield; C4:C6, 3:2, separable mixture). Interestingly, 5-Cl benzimidazole showed a different selectivity, and was trifluoromethylated at positions C4 and C7 (2g, 45%; C4:C7 2:1) probably due to the electronic and steric effect of the chlorine atom. Notably, the possibility to easily separate the regioisomers obtained in compounds 2d to 2g renders our strategy advantageous for the simultaneous synthesis of fluorinated analogues relevant for medicinal chemistry SAR studies. Next, we tested pyridone and pyrimidone, which are frequently used scaffolds in the synthesis of novel active pharmaceutical ingredients (APIs). 14 Trifluoromethylated pyrimidone 3a and Br-pyridone 3b were obtained in good to excellent yields (80% and 60% respectively). We further investigated the reactivity of pyridine, obtaining trifluoromethylated pyridine derivatives 3d, 3e and 3f in modest yields (40%, 35% and 53%). Furthermore, 4-Ph pyrazole could be trifluoromethylated on the phenyl substituent and isolated in 28% yield (3g). Conversely, the tetrahydropyran-substituted 4-amino pyrazole derivative 3h was trifluoromethylated at position C5 on the pyrazole ring and isolated in a reasonable 45% yield.
Br-dimethyl pyridine 3i was successfully trifluoromethylated in 38% yield. Finally, we explored the scope of our methodology with regard to unactivated arene substrates. Trifluoromethylated mesitylene and iodo mesitylene 3j and 3k were obtained in good to excellent yields, 53% and 80% respectively. Trifluoromethylation of unactivated arenes is a particularly challenging transformation, often requiring long reaction times (18-24 hours) , and so far rarely reported in photoredox-based protocols. 4h, 15 Therefore, we were pleased to observe significant product formation in our system within only 30 minutes reaction time. The main reason for the remarkable acceleration of the reaction rate observed in our protocol lies in the improved irradiation of the reaction mixture obtained in the microflow reactor. 11, 16 Moreover, to showcase the potential of microreactors in terms of productivity, we performed a scale-up experiment on Br-pyridone. 16c, 17 The vapourtec UV-150 photoreactor was continuously run for 3.5 hours without any intervention, affording 545 mg of trifluoromethylated derivative 3b (56%).
In conclusion, we developed a continuous-flow trifluoromethylation strategy for arenes, heteroarenes and benzofused heterocycles. Luminescence quenching studies were employed to accelerate initial protocol optimization and to select the best photocatalyst for the transformation. Easy to handle CF3SO2Na (Langlois' reagent) was successfully used as trifluoromethylating agent. A variety of substrates of high interest in drug discovery programs were trifluoromethylated in good to excellent yields. Moreover, bromo, chloro and iodo containing substrates were well tolerated, thus demonstrating the compatibility of our methodology with cross-coupling methods. Process intensification in a microflow reactor afforded reduced reaction times (30 minutes residence time) and a high productivity. Therefore, we anticipate that our methodology will find application in the late stage functionalization of pharmaceutical ingredients as well as in the preparation of key intermediates in drug discovery programs.
The experimental section has no title; please leave this line here.
The UPLC (Ultra Performance Liquid Chromatography) measurement was performed using an Acquity ® IClass UPLC ® (Waters) system comprising a
Template for SYNTHESIS © Thieme Stuttgart · New York 2019-02-25 page 4 of 7 sampler organizer, a binary pump with degasser, a column oven, a diodearray detector (DAD) and a column as specified below. The MS detector (Waters, SQD or QTOF) was configured with an ESCI dual ionization source (electrospray combined with atmospheric pressure chemical ionization). Nitrogen was used as the nebulizer gas. The source temperature was maintained at 140 °C. Data acquisition was performed with MassLynx-Openlynx software.
For IClass-SQD: Reversed phase UPLC was carried out on a RRHD Eclipse Plus-C18 (1.8 μm, 2.1 x 50 mm) from Agilent, with a flow rate of 1.0 ml/min, at 50ºC. The gradient conditions used are: 95 % A (0.5 g/l ammonium acetate solution + 5 % acetonitrile), 5 % B (acetonitrile), to 40 % A, 60 % B in 1.2 minutes, to 5% A, 95% B in 0.6 minutes, held for 0.2 minutes. Injection volume 1.0 μl. Low-resolution ESI mass spectra (single quadrupole, SQD detector) were acquired by scanning from 100 to 1000 in 0.1 seconds using an inter-channel delay of 0.08 second. The capillary needle voltage was 3 kV. The cone voltage was 25 V for positive ionization mode and 30 V for negative ionization mode.
For IClass-QTOF: Reversed phase UPLC was carried out on a BEH-C18 (1.7 μm, 2.1 x 50 mm) from Waters, with a flow rate of 1.0 ml/min, at 50ºC. The gradient conditions used are: 95 % A (0.5 g/l ammonium acetate solution + 5 % acetonitrile), 5 % B (acetonitrile), to 40 % A, 60 % B in 1.2 minutes, to 5% A, 95% B in 0.6 minutes, held for 0.2 minutes. Injection volume 1.0 μl. High resolution ESI mass spectra were recorded on a Xevo G2-S QTOF mass spectrometer (Waters) configured with an electrospray ionization source, maintained at 140 ºC, using nitrogen as the nebulizer gas, argon as collision gas and Lockmass device for mass calibration using Leucine-Enkephalin as standard substance. Spectra were acquired either in positive or in negative ionization mode, by scanning from 50 to 1200 Da in 0.1 s. In positive mode the capillary needle voltage was 0.25 kV and the cone voltage was 25 V. In negative mode the capillary needle voltage was 2.0 kV and the cone voltage was 25 V.
GCMS:
GC measurements were performed using a 6890 Series Gas Chromatograph (Agilent Technologies) system comprising a 7683 Series injector and auto sampler, J&W HP-5MS column (20 m x 0.18 mm, 0.18 nologies coupled to a 5973N MSD Mass Selective Detector (single quadrupole, Agilent Technologies). The MS detector was configured with an electronic impact ionization source/chemical ionization source (EI/CI). EI low-resolution mass spectra were acquired by scanning from 50 to 550 at a rate of 5.51 scan/s. The source gas. Data acquisition was performed with Chemstation-Open Action software.
Thin layer chromatography (TLC) was carried out on silica gel 60 F254 plates (Merck) using reagent grade solvents. Unless otherwise specified, reagents were obtained from commercial sources and used without further purification. The reactions were carried out in a Vapourtec photoreactor UV-150 fixed on an E-series Vapourtec equipment. 1 H NMR spectra were recorded on Bruker DPX-400 or Bruker AV-500 spectrometers with standard pulse sequences, operating at 400MHz and 500MHz respectively. Chemical shifts () are reported in parts per million (ppm) downfield from tetramethylsilane (TMS), which was used as an internal standard. All microfluidic fittings were purchased from IDEX Health and Science. The syringes were connected to the capillary using ¼-28 flat-bottom flangeless fittings. A syringe pump (Fusion 200 Classic) equipped with 5 or 10 mL syringes was used to feed liquid reagents through a high purity perfluoroalkoxyalkane (PFA) capillary tubing (ID = 1.3 mm) to a Tefzel® tee mixer (ID = 1.25 mm)..
Procedures
General procedure: In an oven-dried vial equipped with a magnetic stirrer and a PTFE septum, 5.6 mg (1 mol %) of [Ir{dF(CF3)ppy}2](dtbpy)]PF6 was added to a mixture of the hetero-arene substrate (0.5 mmol, 1 equiv.), NaSO2CF3 (1.5 mmol, 3 equiv.) and (NH4)2S2O8 (0.5 mmol, 1 equiv.) in 5 ml of DMSO. The solution was pumped into the Vapourtec Photoreactor (fluoropolymer tube, 1.3 mm ID, 10 mL) and the liquid flowrate was set at 0.33 mL/min (30 minutes residence time). The reactor was irradiated with 54 blue LEDs (450 nm, total power 24W). The reaction mixture collected from the outlet was diluted with H2O and extracted with Et2O (3x). The combined organic layers were washed with brine, dried over MgSO4 and concentrated in vacuo. The crude was then pre-adsorbed onto silica, dried in vacuo and purified by flash chromatography to yield the trifluoromethlyated product. 3, (2a) 6a : Product prepared according to the general procedure, purification in flash chromatography on silica gel using as eluent heptane/ethyl acetate 75/25 afforded the desired product as a white solid (59 mg, 45%. M.p. = 130.85 °C).
1H-
1 H NMR (500MHz, CDCl3): δ = 4.14-4.19 (m, 3H), 3.60 (s, 3H), 3.42 ppm (s, 3H). 13 C NMR (101MHz, CDCl3): δ = 155. 5, 151.3, 146.5, 138.9, 119.5, 109.6, 33.2, 29.9, 28 18 ; Product prepared according to the general procedure, purification in flash chromatography on silica gel using as eluent heptane/ethyl acetate 80/20 afforded the desired product as a white solid (61.8 mg, 62%. M.p. = amorphous solid).
3-methyl-2-(trifluoromethyl)-1H-indole (2b)
1 H NMR (400MHz, CDCl3): δ = 8. 18 (br s, 1H), 7.64 (d, J=8.1 Hz, 1H), 1H), 1H), 1H) , 2.45 ppm (q, J=1.8 Hz, 3H). 13 C NMR (101MHz, CDCl3): δ = 135. 2, 128.1, 124.8, 124.6, 121.6, 122.2, 120.1, 114.1, 8.4 ppm. 
2-methyl-3-(trifluoromethyl)-1H-indole
(2c) 4f : Product prepared according to the general procedure, purification in flash chromatography on silica gel using as eluent heptane/ethyl acetate 80/20 afforded the desired product as a white solid (68,7 mg. 69%. M.p. = 147.45 °C).
1 H NMR (500MHz, CDCl3): δ = 8. 18 (br s, 1H), 7.67 (br d, J=7.5 Hz, 1H), 1H), 2H) , 2.49 ppm (s, 3H). 13 C NMR (101MHz, CDCl3): δ = 133. 9, 121.8, 121.3, 120.2, 119.1, 117.3, 113.7, 110.7, 99.3, 12 .4 ppm. 
5-iodo-3-(trifluoromethyl)-1H-indole (2d);
Product prepared according to the general procedure, purification in flash chromatography on silica gel using as eluent heptane/ethyl acetate 90/10 afforded the desired product as a transparent oil (39 mg, 25%).
1 H NMR (400MHz, CDCl3): δ = 8.47 (br s, 1H), 8.10 (s, 1H), 7.56 (dd, J=8.6, 1.6 Hz, 1H), 7.51 (dd, J=2.7, 1.3 Hz, 1H) , 7.23 ppm (s, 1H). 13 C NMR (101MHz, CDCl3): δ = 138.0, 134.9, 132.2, 128.4, 125.1, 125.0, 124.2, 113.5, 85 .2 ppm. 
5-iodo-2-(trifluoromethyl)-1H-indole (2d):
Product prepared according to the general procedure, purification in flash chromatography on silica gel using as eluent heptane/ethylacetate 80/20 afforded the desired product as a transparent oil (39 mg, 25%). 2-bromo-6-(trifluoromethyl)benzimidazole (2f C4:C6 3:2): Product prepared according to the general procedure, purification in flash chromatography on silica gel using as eluent heptane/ethylacetate in gradient from 100/0 to 50/50 afforded the desired product as a white solid (26.7 mg, 20%. M.p. = 214.7 °C).
1 H NMR (400MHz, CDCl3): δ = 8.25 (s, 1H), 7.99 (s, 1H), 7.74 (d, J=8.6 Hz, 1H), 7.57 ppm (d, J=8.6 Hz, 1H). 13 C NMR (101MHz, CDCl3): δ = 142. 6, 128.7, 126.0, 125.7, 125.4, 123.3, 120 .1 ppm. 19 
1-tetrahydropyran-4-yl-5-(trifluoromethyl)pyrazol-4-amine (3h):
Product prepared according to the general procedure, purification in flash chromatography on silica gel using as eluent heptane/ethylacetate 50/50 afforded the desired product as a dark yellow oil (52.9 mg, 45% 3-bromo-2,6-dimethyl-5-(trifluoromethyl) pyridine (3i); Product prepared according the general procedure. The organic layer was evaporated and the crude was analysed by LC-MS (38%).
